Skip to content
Trial Agents

Sanquin Diagnostiek

Sanquin Diagnostiek is recorded as a service provider in 6 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.

6distinct trials
2recorded service labels
0trials with learnings

Data snapshot: 2026-10-09 · About the data

Clinical trial experience

Showing 6 of 6 trials · Latest update first

A Phase 3, Multi-Center Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of Risankizumab with Open-Label Induction, Randomized Double-Blind Maintenance, and Long-Term Extension Periods in Pediatric Subjects (2 to < 18 Years of Age) with Moderately to Severely Active Crohn's Disease

Sponsor Abbvie Deutschland GmbH & Co. KG

Start (EU)
Latest update
Estimated end

Questions about this trial experience

What services are recorded for Sanquin Diagnostiek?

The 2026-10-09 snapshot links Sanquin Diagnostiek to 6 distinct CTIS trials. Recorded services include Laboratory services, PD analysis (total C2, CH50). These are study-specific roles, not a complete or independently verified capability catalogue.

Which therapeutic areas and study phases are recorded for Sanquin Diagnostiek?

The most frequently recorded therapeutic areas are Immunology, Blood Disorders, Gastroenterology, Neurology. Recorded phases include Phase 3, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.

In which countries are trials linked to Sanquin Diagnostiek conducted?

The linked trials record locations in 17 countries, including Belgium, Germany, Italy, Netherlands, Spain. These are trial locations, not confirmed office locations or countries where Sanquin Diagnostiek delivered services.

What can this page tell me about Sanquin Diagnostiek's trial experience?

Browse 6 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.

About this data & company names

One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.

Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.

Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Sanquin Diagnostiek. Legacy brands remain separate unless explicitly matched in the name registry.

View recorded company names
  • Sanquin Diagnostiek B.V.

Never miss a new clinical trial insight

We continuously analyze new and updated clinical trial data and publish practical, evidence-led reports for clinical leaders.